| |
| |
|
| Insider
Information: |
Hirsch Stanley |
| Relationship: |
Director |
| City: |
Rehovot |
| State: |
L3 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
201,410 |
|
|
Indirect Shares
|
387,625 |
|
|
| Direct
Value |
$45,015 |
|
|
|
Indirect Value
|
$264,656 |
|
|
| Total
Shares |
589,035 |
|
|
| Total
Value |
$309,671 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Foamix Pharmaceuticals Ltd |
FOMX |
Director |
2020-03-09 |
0 |
2020-03-09 |
59,016 |
Premium* |
|
|
VYNE Therapeutics Inc |
VYNE |
Director |
2020-04-03 |
201,410 |
2020-04-03 |
328,609 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VYNE |
VYNE Therapeutics Inc |
Director |
– • – |
2020-04-03 |
4 |
A |
$0.00 |
$0 |
D/D |
135,147 |
201,410 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Director |
– • – |
2020-04-03 |
4 |
A |
$0.00 |
$0 |
I/I |
220,496 |
328,609 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Director |
– • – |
2020-03-09 |
4 |
A |
$0.00 |
$0 |
D/D |
66,263 |
66,263 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Director |
– • – |
2020-03-09 |
4 |
A |
$0.00 |
$0 |
I/I |
108,113 |
108,113 |
0 |
- |
|
| FOMX |
Foamix Pharmaceuticals Lt... |
Director |
– • – |
2020-03-09 |
4 |
D |
$0.00 |
$0 |
D/D |
(111,858) |
0 |
0 |
- |
|
| FOMX |
Foamix Pharmaceuticals Lt... |
Director |
– • – |
2020-03-09 |
4 |
D |
$0.00 |
$0 |
I/I |
(182,500) |
59,016 |
0 |
- |
|
| FOMX |
Foamix Pharmaceuticals Lt... |
Director |
– • – |
2020-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
42,493 |
111,858 |
0 |
- |
|
| FOMX |
Foamix Pharmaceuticals Lt... |
Director |
– • – |
2019-11-04 |
4 |
OE |
$0.62 |
$20,150 |
I/I |
32,500 |
182,500 |
0 |
- |
|
| FOMX |
Foamix Pharmaceuticals Lt... |
Director |
– • – |
2019-10-15 |
4 |
OE |
$0.62 |
$55,800 |
I/I |
90,000 |
150,000 |
0 |
- |
|
| FOMX |
Foamix Pharmaceuticals Lt... |
Director |
– • – |
2019-08-13 |
4 |
OE |
$0.62 |
$37,200 |
I/I |
60,000 |
60,000 |
0 |
- |
|
| FOMX |
Foamix Pharmaceuticals Lt... |
Director |
– • – |
2019-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
56,391 |
69,365 |
0 |
- |
|
| FOMX |
Foamix Pharmaceuticals Lt... |
Director |
– • – |
2018-07-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,616 |
12,974 |
0 |
- |
|
| FOMX |
Foamix Pharmaceuticals Lt... |
Director |
– • – |
2018-05-13 |
4 |
S |
$5.09 |
$31,369 |
D/D |
(6,164) |
6,508 |
0 |
- |
|
| FOMX |
Foamix Pharmaceuticals Lt... |
Director |
– • – |
2018-05-13 |
4 |
OE |
$5.04 |
$31,369 |
D/D |
6,224 |
12,672 |
0 |
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
